XERS
Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ · Healthcare
Xeris Biopharma Holdings, Inc. annual/quarterly cash on hand history from 2020 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Xeris Biopharma Holdings, Inc. cash on hand for the quarter ending December 31, 2025 were 111.0M, a 55.04% increase year-over-year.
- Xeris Biopharma Holdings, Inc. cash on hand for 2025 were 111.0M, a 55.04% increase from 2024.
- Xeris Biopharma Holdings, Inc. cash on hand for 2024 were 71.6M, a 6.19% increase from 2023.
- Xeris Biopharma Holdings, Inc. cash on hand for 2023 were 67.4M, a 44.70% decrease from 2022.
- Xeris Biopharma Holdings, Inc. cash on hand for 2022 were 122.0M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Xeris Biopharma Holdings, Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $111 |
| 2024 | $72 |
| 2023 | $67 |
| 2022 | $122 |
| 2021 | $67 |
| 2020 | $38 |
| Xeris Biopharma Holdings, Inc. Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2025-12-31 | $111 |
| 2024-12-31 | $72 |
| 2023-12-31 | $67 |
| 2022-12-31 | $122 |
| 2021-12-31 | $67 |
| 2020-12-31 | $38 |
Xeris Biopharma Holdings, Inc. Cash on Hand — FAQ
Xeris Biopharma Holdings, Inc. (XERS) cash on hand over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see XERS's cash on hand history?
The chart and table above show Xeris Biopharma Holdings, Inc.'s cash on hand by year and by quarter, including the growth rate.